C
linicopathologic studies indicate that the severity of the Alzheimer disease (AD) pathology is correlated with greater cognitive and functional decline, [1] [2] [3] but there is an important discordance. The progressive accumulation of neuritic plaques (NPs) and neurofibrillary tangles (NFTs) develops before clinical symptoms start to emerge, 4,5 but even with severe underlying AD pathology a significant number of individuals remain cognitively intact, reflecting resilience to the ravages of disease. 6, 7 It is possible that these subjects manifest other manifestations of AD, including psychotic symptoms, preceding cognitive impairments.
Mild behavioral impairment (MBI) has been used in recent years to describe later-life manifestations of neuropsychiatric symptoms (NPS) in the absence of cognitive deficits or in patients with mild cognitive impairment (MCI). 8 MBI has been linked to increased risk of developing dementia. 8 Psychosis including both delusions and hallucinations are common and clinically distinct NPS of AD. 9 Although previous studies have investigated psychosis in association with cognitive function, 10,11 the pathologic correlates of psychosis in patients with MBI has not been investigated. Identification of NPS in the absence of cognitive decline or MCI may allow us to better differentiate the neurobiology of these common deficits.
The aim of the current study was to examine the substrate of psychotic symptoms in cognitively intact subjects with severe AD pathology, both NP and NFT. Furthermore, we sought to explore the role of other common pathologies including vascular lesions and Lewy body pathology in the clinical manifestation of psychosis among cognitively asymptomatic (cASYM) individuals.
METHODS

Data Source
Data were obtained from the National Alzheimer's Coordinating Center (NACC). The NACC encompasses data from 34 past and present Alzheimer's Disease Centers (ADC). Both the uniform and neuropathology data set collected between September 2005 and December 2015 were obtained for analysis. The UDS was used to collect demographic and clinical characteristics, and the neuropsychiatric profile based on the Neuropsychiatric Inventory Questionnaire, quick version (NPI-Q), which evaluates NPS within the last month before clinical visit. It is important to note that the criteria for delusions on the NPI-Q is mainly persecutory delusions. The neuropathology data set provided information on the density of NP and extent of NFT. The density of NP was classified as sparse, moderate, or frequent NP based on the CERAD criteria. 12 The NFT was classified based on Braak and Braak (B&B) stage of NFT, which include B&B stage I or II, B&B stage III or IV, and B&B stage V or VI. 13 The presence of vascular lesions, including absence or presence of microinfarcts, lacunes, and subcortical arteriosclerotic leukoencephalopathy were also obtained. Presence of lacunes was defined as having ≥ 1 lacunes (small artery infarcts and/or hemorrhages). Presence of Lewy body pathology was defined as having brainstem, transitional, including amygdala, or diffuse Lewy bodies. 14 Lewy bodies in the olfactory bulb or regions unspecified were not considered.
Subject Criteria
The time interval between last clinical visit and death was limited to 2 years. Subjects with symptoms of delusions or hallucinations at any point during the course of their illness were categorized as having psychosis. Delusions and hallucinations were not analyzed separately due to limited sample size.
On the basis of criteria reported in the current literature, subjects with Mini-Mental Status Examination (MMSE) scores of ≥ 24 were categorized as being cognitively intact. [15] [16] [17] Within these groups, subjects with frequent NPs based on CERAD score of frequent NPs were classified as NPcASYM, and those with B&B stage V or VI were classified NTcASYM) (collectively cASYM). Each group was compared with cognitively intact subjects with absent/low or intermediate load of NP and NFT, respectively. The analyses were replicated using the global Clinical Dementia Rating score of 0 or 0.5 (ie, no impairment or questionable impairment) (Supplemental Table 1 , Supplemental Digital Content 1, http://links.lww.com/WAD/ A196).
Subjects with the following primary pathologic diagnoses were excluded: amyotrophic lateral sclerosis, prion disease, trinucleotide disease (ie, Huntington disease, spinocerebellar ataxia, other), malformation of cortical development, white matter disease (ie, multiple sclerosis or other demyelinating disease), neoplasm (primary and metastatic), frontotemporal lobar degeneration with tau pathology.
Statistical Analyses
The relationship between variables was studied using descriptive statistics. For categorical data, the χ 2 test was used. For continuous data, the Kolmogorov-Smirnov test of normality was first used to evaluate the normality. The independent sample t test or Mann-Whitney test was used for data with normal or non-normal distribution respectively. The cASYM group was analyzed with respect to the NP density (sparse, moderate, or frequent) and the NFT category (dichotomized as: B&B stage I or II, B&B stage III or IV, and B&B stage V or VI). The relationship between NPcASYM or NTcASYM status and psychosis was investigated by fitting logistic regression models, sequentially adjusting for age, sex, and educational status (model B), the additional effect of presence of Lewy body pathology and microinfarcts (model C); and the effect of AD pathology (model D). The association is reported as Odds ratios (ORs) with 95% confidence intervals (CIs). Statistical analysis was performed using SPSS version 23.0 (SPSS Inc., Chicago, IL). The significance level was set at α = 0.05.
RESULTS
Subject Demographics
On the NACC database, 3835 subjects had autopsy data, and 3106 had autopsy performed within 2 years of last clinical visit. Among these subjects, 2032 had MMSE score available, of which 736 subjects had MMSE score of ≥ 24. Among 736 subjects, 708 had NPI-Q score available, and 3 were missing AD pathology data, and 38 were excluded due to other pathologic diagnoses. In total, 667 subjects were included. Further categorization of subjects in different categories of AD pathology are displayed in Figure 1 . Not all subjects with AD pathology data had record on vascular lesions (ie, microinfarcts (n = 665), lacunes (n = 587), subcortical arteriosclerotic leukoencephalopathy (n = 586), Lewy body pathology (n = 646)). Table 1 compares the demographic and clinical characteristics of the cASYM group by NP density and NFT categories. An inverse relation was noted between MMSE score and NP density and NFT category, with lower MMSE score more likely with higher NP density or higher NFT category (P < 0.05). Table 2 shows the distribution of the severity of AD pathology, vascular lesions, and Lewy body pathology according to psychosis status. Although not included in the analysis, the sample size for subjects with both delusions and hallucinations are also shown. The percentage distribution of psychotic subjects was highest in the category with frequent NP compared with the category with moderate or spare/no NP (20% vs. 8% vs. 10%, P < 0.05). The differences between psychotic and nonpsychotic subjects in the distribution of NFT, microinfarcts, lacunes, subcortical arteriosclerotic leukoencephalopathy, and Lewy body pathology did not reach statistical significance. Table 3 shows the results from the regression analysis. In unadjusted analysis (model A), NPcASYM were at significantly higher risk of having psychosis, compared with those with moderate or sparse/no NP (OR, 2.47; 95% CI, 1.54-3.96). Adjusting for clinical confounders had marginal impact on the strength of the association (OR, 2.55; 95% CI, 1.58-4.11). Further adjustment for Lewy body pathology and microinfarcts had a slight effect on the association with the OR reduced from 2.55 to 2.26. Adjusting for the additional effect of B&B stage, reduced the OR to 2.13 (95% CI, 1.09-4.17). In the unadjusted analysis, NTcASYM were at significantly higher risk of psychosis compared with their counterparts who were B&B stage I to III (OR, 1.88; 95% CI, 1.05-3.38). Adjusting for demographic confounders had no effect on the strength of the association (OR, 1.89; 95% CI, 1.05-3.42). However, further adjustment for Lewy body pathology and microinfarcts resulted to a loss of the association (OR, 1.75; 95% CI, 0.87-3.52). 
Psychosis in cASYM Subjects
DISCUSSION
Clinicopathologic studies investigating the correlation between AD pathology and cognitive status demonstrated a differential effect of NFT and NP. NFT have been identified as a prominent indicator of cognitive decline. [18] [19] [20] Findings from the present study suggest that NP may be important predictors of noncognitive clinical manifestations, specifically psychosis. The association between NP and psychosis was independent of demographic factors, vascular pathology, and the severity of NFT. Vascular lesions have been previously identified as a major risk factor for psychosis in AD through clinicopathologic and neuroimaging studies. [21] [22] [23] Furthermore, Lewy body pathology is a known risk factor for hallucinations. 24 The results of our study did not show an independent association between vascular lesions and Lewy bodies on psychosis. Although an association between NFT and psychosis was observed, this association was dependent on effect of vascular lesions and Lewy bodies. However, as our study was cross sectional, further longitudinal studies may allow for better differentiate the role of NFT, vascular lesions, and Lewy bodies in the manifestation of psychosis. Furthermore, while a significant correlation was found between the MMSE scores in cASYM subjects with severe compared with mild AD pathology, the difference in the scores were clinically negligible.
The present study has several limitations. First of all, delusions and hallucinations were not analyzed separately due to limited sample size. As previous studies have suggested different neurobiology behind delusions and hallucination, further studies are needed to investigate whether NP have differential effect on inducing delusions and hallucinations in cognitively intact subjects. 25 Another important limitation is that we used an arbitrary cutoff MMSE score of 24 to define cognitively intact subjects. This cutoff is considered clinically appropriate and has been frequently used in previous studies, but does not capture subtle cognitive deficits. [15] [16] [17] Therefore, our subject sample does not exclude MCI. Moreover, missing data might have caused attrition bias, potentially confounding our results. Further studies using a more extensive cognitive examination and complete data on AD pathology is needed to confirm our findings.
In conclusion, this study has demonstrated that in cASYM subjects, AD pathology, specifically the severity of NP, is associated with higher risk of psychosis. Going forward, longitudinal studies examining the progression of NP and other risk factors may be needed to better understand the neurobiology leading to the divergence in clinical manifestations. 
